Analysis and Commentary STEVEN GROSSMAN 3/19/20 Analysis and Commentary STEVEN GROSSMAN 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More Analysis and Commentary STEVEN GROSSMAN 2/21/20 Analysis and Commentary STEVEN GROSSMAN 2/21/20 TMAP: Planning for Efficient, Effective Data Management at FDA Read More Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More STEVEN GROSSMAN 2/20/20 STEVEN GROSSMAN 2/20/20 Join Us for Our Annual Hill Day on March 18! Read More STEVEN GROSSMAN 2/19/20 STEVEN GROSSMAN 2/19/20 Alliance for a Stronger FDA Announces New Officers for 2020 Read More Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More STEVEN GROSSMAN 2/11/20 STEVEN GROSSMAN 2/11/20 Alliance Issues Analysis of President's FY 21 Request for FDA Funding Read More Analysis and Commentary STEVEN GROSSMAN 2/7/20 Analysis and Commentary STEVEN GROSSMAN 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 3/19/20 Analysis and Commentary STEVEN GROSSMAN 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More
Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Advocacy at a Glance STEVEN GROSSMAN 3/20/20 Alliance Completes Hill Day with Conference Calls and Much Enthusiasm on Both Sides Read More
Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/20 Advocacy at a Glance STEVEN GROSSMAN 3/13/20 The Alliance’s March 18 Hill Day Is Still On; New Format to Deliver FDA Funding Message Safely Read More
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Advocacy at a Glance STEVEN GROSSMAN 2/28/20 Coronavirus Supplemental Likely to Be Considered Quickly Read More
Analysis and Commentary STEVEN GROSSMAN 2/21/20 Analysis and Commentary STEVEN GROSSMAN 2/21/20 TMAP: Planning for Efficient, Effective Data Management at FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
STEVEN GROSSMAN 2/20/20 STEVEN GROSSMAN 2/20/20 Join Us for Our Annual Hill Day on March 18! Read More
STEVEN GROSSMAN 2/19/20 STEVEN GROSSMAN 2/19/20 Alliance for a Stronger FDA Announces New Officers for 2020 Read More
Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More
Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More
STEVEN GROSSMAN 2/11/20 STEVEN GROSSMAN 2/11/20 Alliance Issues Analysis of President's FY 21 Request for FDA Funding Read More
Analysis and Commentary STEVEN GROSSMAN 2/7/20 Analysis and Commentary STEVEN GROSSMAN 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/20 Analysis and Commentary STEVEN GROSSMAN 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Advocacy at a Glance STEVEN GROSSMAN 2/1/20 Upcoming Hill Opportunity for Alliance Members Read More
Analysis and Commentary STEVEN GROSSMAN 1/25/20 Analysis and Commentary STEVEN GROSSMAN 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More
